Trump tariffs pharmaceuticals, exempting companies with US sites, aim to boost domestic production and impact global market dynamics.
Browsing: Top News
FDA warning letters target misleading drug ads, raising concerns about agency’s staffing for enforcement.
A snapshot of August 2025’s top pharma and biopharma developments — highlighting $185.28B in deal value, four FDA approvals, and EMA’s regulatory focus on AI
European Parliament’s SANT Committee urges for greater control on medicine provisions to help strengthen security of supply.